Patient-Doctor Contact Interval and Clinical Outcomes in Continuous Ambulatory Peritoneal Dialysis Patients
Patient-Doctor Contact Interval and Clinical Outcomes in Continuous Ambulatory Peritoneal Dialysis Patients
复制标题
连续门诊腹膜透析患者的医患接触间隔和临床结果
DOI:
10.1159/000464258
复制
发表时间:
2017-03
影响因子:
4.2
通讯作者:
Yang Xiao
中科院分区:
文献类型:
--
作者:
Yi Chunyan;Guo Qunying;Lin Jianxiong;Li Jianying;Yu Xueqing;Yang Xiao
Background: The optimal patient-doctor contact (PDC) interval remains unknown in peritoneal dialysis (PD) patients. The aim was to investigate the association between PDC interval and clinical outcomes in continuous ambulatory PD (CAPD) patients. Methods: In this retrospective cohort study, CAPD patients who resided in Guangzhou city between January 2006 and December 2012 were included. According to receiver operating characteristic curve analysis, all patients were classified as high (PDC interval ≤2 months) and low (PDC interval >2 months) PDC frequency groups. Biochemical data, clinical events, and clinical outcomes during the follow-up period were compared. Results: Of 433 CAPD patients, the mean age was 51.3 ± 15.7 years, 54.3% of patients were male, and 29.1% with diabetes. The median vintage of PD was 45.8 (26.3-69.1) months. Patients with high PDC frequency (n = 233) had better patient-survival rates (99.6, 87.7, and 76.5% vs. 92.7, 76.5, and 58.7% at 1, 3, and 5 years; p < 0.001), lower peritonitis rate (0.17 vs. 0.23 episodes per patient-year; p < 0.001), and hospitalization rate (0.49 vs. 0.67 episodes per patient-year; p < 0.001) than those in the low PDC frequency group (n = 200). After adjustment for confounders, PDC interval of no more than 2 months was independently associated with better patient survival (hazard ratio 0.60, 95% CI 0.42-0.86, p = 0.006). Conclusion: A PDC interval of 2 months or less was associated with better clinical outcomes in CAPD patients. This indicates that a shorter PDC interval should be encouraged for them to achieve better clinical outcomes.
登录
查看更多内容
影响因子:
2.6
作者:
Plantinga, LC;Jaar, BG;Powe, NR
通讯作者:
Powe, NR
DOI:
10.1097/01.asn.0000106101.48237.9d
发表时间:
2004-01-01
影响因子:
13.6
作者:
Plantinga, LC;Fink, NE;Powe, NR
通讯作者:
Powe, NR
影响因子:
--
作者:
Yumi Kimura;Tsutomu Inoue;Hiromichi Suzuki
通讯作者:
Yumi Kimura;Tsutomu Inoue;Hiromichi Suzuki
影响因子:
13.6
作者:
Kawaguchi, Takehiko;Karaboyas, Angelo;Saran, Rajiv
通讯作者:
Saran, Rajiv
DOI:
--
发表时间:
1998-10
期刊:
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
影响因子:
--
作者:
N. Roos;K. Carriere;D. Friesen
通讯作者:
N. Roos;K. Carriere;D. Friesen